Nanjing Dorra Pharmaceutical Technology Co. Ltd.

CAS No.960404-48-2 
In-house

CAS No.464-43-7
In-house

CAS No.1050477-31-0
Standard：In-house

CAS NO:808118-40-3
In-house

CAS No.1260141-27-2
In-house

Makou plant, which is located in Makou industrial Zone, Tian Town, Wuxue City, Hubei Province,covers an area of 230000 square meters, including one administration building, six buildings of production workshop ( with 5000 square meters of Class D clean area), four warehouse buildings (equipped with refrigeration storage) and three sets of purified water systems. Currently, there are 530 employees in total, among which 380 are production personnel, 28 are quality assurance personnel, and 45 are QC personnel. The total capacity of reactor is 2 million litres. The annual production output can reach 8000 tons. Up to now, the plant has been approved by CFDA, Japan PMDA, FDA, etc. Hejin plant, which is located in Hejin Industrial Park, Yuncheng City, Shanxi Province, covers an area of 80000 square meters, with the building area of 28800 square meters. There are one office building, one building for penicillin workshop, one building for solid preparation (including tablets, capsule...

Dorrapharma is engaged in R&D, manufacture and market of intermediates, APls (Active Pharmaceutical Ingredients) and formulations. We own the core technology advantage in the professional area of bromination, enzyme/metal­catalyzed, nitration and hydrogenation, and obtain multiple core patents for invention. We stick to raising the value both for the company and customers, and devote ourselves completely to the technology innovation and brand build and make every effort to foster the core competence for the company with the company mission of a leading pharmaceutical integrated operator with its core competitive advantage in global market.